Sequence information
Variant position: 121 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 374 The length of the canonical sequence.
Location on the sequence:
KFKFSILNAKGEETKAMESQ
R AYRFVQGKDWGFKKFIRRDF
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human KFKFSILNAKGEETKAMESQR AYRFVQGKDWGFKKFIRRDF
Mouse KFKFSILNAKGEETKAMESQR AYRFVQGKDWGFKKFIRRDF
Bovine KFKFSILNAKGEETKAMESQR AYRFVQGKDWGFKKFIRRDF
Xenopus tropicalis KFKFSILNAKGEETKAMESQR AYRFVQGKDWGFKKFIRRDF
Zebrafish KFKFSILNAKGEETKAMESQR AYRFVQGKDWGFKKFIRRDF
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 374
Speckle-type POZ protein
Domain
31 – 161
MATH
Region
71 – 191
Required for nuclear localization
Mutagenesis
123 – 123
Y -> A. Strongly reduced affinity for substrate proteins.
Mutagenesis
130 – 130
D -> A. Strongly reduced affinity for substrate proteins.
Mutagenesis
131 – 131
W -> A. Strongly reduced affinity for substrate proteins.
Mutagenesis
133 – 133
F -> A. Strongly reduced affinity for substrate proteins.
Literature citations
De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders.
Nabais Sa M.J.; El Tekle G.; de Brouwer A.P.M.; Sawyer S.L.; Del Gaudio D.; Parker M.J.; Kanani F.; van den Boogaard M.H.; van Gassen K.; Van Allen M.I.; Wierenga K.; Purcarin G.; Elias E.R.; Begtrup A.; Keller-Ramey J.; Bernasocchi T.; van de Wiel L.; Gilissen C.; Venselaar H.; Pfundt R.; Vissers L.E.L.M.; Theurillat J.P.; de Vries B.B.A.;
Am. J. Hum. Genet. 106:405-411(2020)
Cited for: VARIANTS NSDVS2 ALA-25; CYS-83; VAL-132 AND CYS-138; CHARACTERIZATION OF VARIANTS NSDVS2 ALA-25; CYS-83; VAL-132 AND CYS-138; VARIANTS NSDVS1 GLN-121 AND ASN-144; CHARACTERIZATION OF VARIANTS NSDVS1 GLN-121 AND ASN-144; FUNCTION;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.